| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.099 | 0.02 |